Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Page 1
The impact of imbalances in baseline stroke severity on outcome in the National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study.
Ann Emerg Med. 2005 Apr;45(4):377-84. doi: 10.1016/j.annemergmed.2004.06.021.
Ann Emerg Med. 2005.
PMID: 15795715
Clinical Trial.
Recombinant tissue plasminogen activator for minor strokes: the National Institute of Neurological Disorders and Stroke rt-PA Stroke Study experience.
National Institute of Neurological Disorders Stroke rt-PA Stroke Study Group.
National Institute of Neurological Disorders Stroke rt-PA Stroke Study Group.
Ann Emerg Med. 2005 Sep;46(3):243-52. doi: 10.1016/j.annemergmed.2005.02.013.
Ann Emerg Med. 2005.
PMID: 16126134
Clinical Trial.
Item in Clipboard
Cite
Cite